Riskpilot← Back to searchSign inGet full accessÅNDALSNES VETERINÆRKLINIKK AS
ASActiveOrg 822202012Risengata 3, 6300 ÅndalsnesVeterinary activities · NACE 7500Est. 20191 employees
Revenue 2024
NOK 2,3M
+7% vs 2023
EBITDA margin
-0.5%
-118% vs 2023
Equity ratio
66.5%
Financial strength
Net profit 2024
NOK -17K
-138% vs 2023
| Revenue | NOK 2,3M | +7% |
| EBITDA | NOK -12K | -118% |
| Net profit | NOK -17K | -138% |
| Total assets | NOK 694K | -14% |
| Equity | NOK 462K | -3% |
| Employees | 1 | — |
Legal name
ÅNDALSNES VETERINÆRKLINIKK AS
Org number
822202012
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
11. februar 2019
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Utgår
Company purpose
Utføre veterinærtjenester.
Address
Risengata 3, 6300 Åndalsnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 626 | 1 548 | 1 677 | 2 151 | 2 292 |
| Staff expenses | −145 | −2 | −0 | −208 | −313 |
| EBITDA | 117 | 142 | 142 | 66 | −12 |
| Depreciation & amort. | −8 | −8 | −8 | −8 | −11 |
| EBIT | 109 | 134 | 134 | 59 | −23 |
| Net financials | 0 | 0 | −0 | −2 | 1 |
| Profit before tax | 109 | 134 | 134 | 57 | −21 |
| Tax | 24 | 60 | 29 | 12 | −5 |
| Net profit | 85 | 74 | 104 | 44 | −17 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 338 | 348 | 499 | 810 | 694 |
| Equity | 225 | 300 | 434 | 478 | 462 |
| Long-term debt | −36 | 1 | 2 | 0 | 0 |
| Short-term debt | 148 | 47 | 62 | 331 | 232 |
| Total debt | 112 | 48 | 64 | 332 | 232 |
EBITDA margin
-0.5%
This company
15.8%
Market median
-103% vs market
20202024
Equity ratio
66.5%
This company
38.2%
Market median
+74% vs market
20202024
Return on equity
-3.6%
This company
18.4%
Market median
-120% vs market
20202024
Net profit margin
-0.7%
This company
8.1%
Market median
-109% vs market
20202024
Asset turnover
3.30×
This company
1.12×
Market median
+195% vs market
20202024
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
LM Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2019 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ÅNDALSNES VETERINÆRKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Peter Valde | Chief Executive Officer | 0 companies |
| Lise Marie Ånestad | Chief Executive Officer | 0 companies |
| Linn Marita Tellefsen | Board of Directors | 0 companies |
| Marlen Strømsøy Langedal | Board of Directors | 0 companies |
| Ida Amdahl Haalien | Board of Directors | 0 companies |